Patent · US Expired

Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids

US5811268A · kind A · utility

7Cited by

0References

17Claims

0Family size

Assignee

Hoechst GmbH · DE

Inventors

Martin Gerl · Kriftel, DE
Cornelia Steinert · Wiesbaden, DE
Manfred Quint · Wiesbaden, DE
Rupert Timpl · Gauting, DE

Key dates

Filing date	Aug 9, 1995
Grant date	Sep 22, 1998
Priority date	—
Expiry date	Aug 9, 2015

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/18
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Monoclonal antibodies directed to the laminin P1 domain for selective immunological determination of native, high molecular weight, intact laminins in body fluids; a process for preparing these antibodies; and their use for diagnosing diseases. These antibodies preferably bind to intact, native laminin, in particular to the structures of the laminin P1 domain of laminin which are folded in a native manner.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.